Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Torrent Pharma Q4 net profit tanks despite jump in revenue; declares ₹9 dividend
Shares of Torrent Pharmaceuticals Ltd ended at ₹4,494.00, up by ₹23.15, or 0.52%, on the BSE.
Shilpa Medicare Q4 results: Shares gain on sharp profit growth, exceptional gains boost earnings
Shilpa Medicare Q4FY26 profit surged to ₹108 crore on higher revenue and exceptional gains, FY26 earnings improved, dividend proposed. The company approved shifting its registered office from Karnataka to Maharashtra, subject to regulatory and shareholder approvals.
Sun Pharma Q4 Results: Profit Jumps 26% Even As Margins Slip; Dividend Declared
Sun Pharma registered exceptional gains worth approximately Rs 1,700 crore in fiscal 2026.
Sun Pharma Q4 Results: Cons profit rises 26% YoY to Rs 2,714 crore; board approves Rs 5/share dividend
Sun Pharma Q4 Results: Profit after tax (PAT) fell 19% sequentially during the quarter under review from Rs 3,369 crore in Q3FY26, while revenue declined 6% from Rs 15,520 crore reported in the October-December quarter of FY26.
Sun Pharma Q4 results 2026: Profit jumps 26% YoY to ₹2,714 crore; recommends final dividend of ₹5 for FY26
Sun Pharma Q4 results 2026: Profit jumped 26% YoY to ₹2,714 crore. Total revenue from operations for the quarter under review rose 12.8% YoY to ₹14,611.79 crore. Sun Pharma's board recommended a final dividend of ₹5 per share of ₹l each.
Jubilant Pharmova Q4 profit declines on margin pressure; revenue rises 19%
Jubilant Pharmova reported 19% revenue growth in Q4FY26, but weaker margins dragged profit lower. Shares turned volatile after earnings, while the company also announced a final dividend of ₹5 per share.
Max Healthcare Q4 results: Cons PAT grows 7% YoY to Rs 342 crore, revenue rises 12%
Max Healthcare Q4FY26 consolidated PAT grew 7% YoY, and revenue increased 12%. Network EBITDA rose 8%. Max Lab and Max@Home saw strong double-digit growth. The company also recommended a final dividend of Rs 2 per equity share for the year.
Max Healthcare Q4 profit, revenue rise on higher patient volumes; declares ₹2 dividend
Shares of Max Healthcare Institute Ltd ended at ₹1,091.55, up by ₹15.25, or 1.42%, on the BSE.
Apollo Hospitals rises 4% to hit 52-week high on Q4 show, dividend news
Apollo Hospitals Enterprise's board has recommended a final dividend of ₹10 per equity share (200 per cent) of face value of ₹5 per share for FY2025-26
Apollo Hospitals Q4 Results: Profit Jumps 36%, Rs 10 Dividend Declared; Check Record Date
Apollo Hospitals Enterprise declared a final dividend of Rs 10 per share.
Apollo Hospitals Q4 Results: Cons PAT jumps 36% YoY to Rs 529 crore, revenue rises 18%; Rs 10 per share dividend declared
Apollo Hospitals reported strong Q4 FY26 results: consolidated PAT surged 36% YoY to Rs 529 crore, and revenue increased 18% to Rs 6,605 crore. EBITDA grew 31% to Rs 1,011 crore. The company declared a Rs 10 dividend.
Apollo Hospitals beats the Street, declares dividend of ₹10 as net profit surges 33%
Shares of Apollo Hospitals Enterprise Ltd ended at ₹8,066.25, up by ₹40.25, or 0.50%, on the BSE.